A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...
The alarm certainly sounded long and loud in 2022 when Abbott recalled Similac, Alimentum, and EleCare powdered infant ...
Gov. Greg Abbott issued a ban on the use of Chinese-backed artificial intelligence and social media apps on Texas government-issued devices Friday afternoon. The proclamation orders the Texas ...
Argus analyst David Toung raised the firm’s price target on Abbott (ABT) to $150 from $145 and keeps a Buy rating on the shares. Abbott’s growth drivers, including the FreeStyle Libre ...
The company, which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor ...
*Abbott completed the acquisition of CSI on April 27, 2023. For purposes of calculating organic sales growth, the impact from this acquired business has been excluded from January through April ...
(RTTNews) - Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates. The company's bottom line totaled $9.229 billion ...
which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback